Mapan Energy Ltd. (MPG) Financials Nov 18, 2014, 11:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Mapan Energy Ltd. (MPG) Financials Nov 18, 2014, 11:10 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Mapan Energy Ltd.


Fiscal year is December-November. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 370,155 273,891 207,000 111,000 135,000
Cost of Goods Sold (COGS) incl. D&A 758,413 282,584 159,000 125,000 148,000
COGS excluding D&A 208,676 169,588 125,000 103,000 133,000
Depreciation & Amortization Expense 549,737 112,996 34,000 22,000 15,000
Depreciation 549,737 112,996 34,000 22,000 15,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (388,258) (8,693) 48,000 (14,000) (13,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 215,701 132,295 117,000 108,000 91,000
Research & Development 0 0 0 - -
Other SG&A 215,701 132,295 117,000 108,000 91,000
Other Operating Expense (230,027) (49,784) 0 0 0
Unusual Expense 625,428 291,984 75,000 63,000 35,000
EBIT after Unusual Expense (625,428) (291,984) (75,000) (63,000) (35,000)
Non Operating Income/Expense 0 1,625 4,000 114,000 168,000
Non-Operating Interest Income 1,558 421 - - -
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 19,123 63,558 50,000 19,000 10,000
Gross Interest Expense 19,123 63,558 50,000 19,000 10,000
Interest Capitalized 0 - 0 0 0
Pretax Income (1.02M) (444,700) (190,000) (90,000) 19,000
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income (1.02M) (444,700) (190,000) (90,000) 19,000
Minority Interest Expense 0 0 0 0 0
Net Income (1.02M) (444,700) (190,000) (90,000) 19,000
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.02M) (444,700) (190,000) (90,000) 19,000
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.02M) (444,700) (190,000) (90,000) 19,000
EPS (Basic) (0.11) (0.05) (0.02) (0.01) 0.00
Basic Shares Outstanding 9.55M 9.55M 11.6M 17.72M 17.72M
EPS (Diluted) (0.11) (0.05) (0.02) (0.01) 0.00
Diluted Shares Outstanding 9.55M 9.55M 11.6M 17.72M 17.72M
EBITDA 175,805 21,792 (35,000) (100,000) (89,000)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuvini Group Limited Achieves Remarkable Growth in 2024

Updated Category News Views 242

Outstanding Financial Performance Delivered by Nuvini Group NEW YORK — Nuvini Group Limited (Nasdaq: NVNI) has released its financial results for the first half of 2024, demonstrating impressive growth across various metrics. The company continues to set the bar high in the realm of private SaaS B2B acquisitions in Latin America. Growth Metrics Highlight Success The...

Continue Reading
MarketFully Expands Reach with Social Element Acquisition

Updated Category News Views 168

MarketFully Enhances Capabilities with New Acquisition Markfully, the leader in InContent Marketing, has broadened its horizons through the acquisition of a prominent global social media agency, Social Element. This strategic move is set to amplify MarketFully's capacity for delivering multilingual content marketing solutions, particularly across social media platforms....

Continue Reading
Lone Star Family Health Center Partners with athenahealth to Enhance Patient Care

Updated Category News Views 717

Lone Star Family Health Center Partners with athenahealth for Enhanced Care Lone Star Family Health Center (LSFHC), a notable health service provider, has made a major decision to transition to athenaOne, a cutting-edge suite of medical software. This strategic move aims to elevate patient care experiences and health outcomes substantially. athenahealth, well-known for...

Continue Reading
Promising Long-Term Results for Zeposia in Multiple Sclerosis

Updated Category News Views 123

Zeposia (ozanimod): A Breakthrough in Multiple Sclerosis Treatment Bristol Myers Squibb has recently shared compelling long-term findings from the Phase 3 DAYBREAK trial on Zeposia (ozanimod). This promising oral treatment has proven effective in managing relapsing forms of multiple sclerosis (MS). The results underscore Zeposia's sustained effectiveness and safety, which...

Continue Reading
Encompass Health Expands Its Rehabilitation Services in Florida

Updated Category News Views 268

Encompass Health Opens New Rehabilitation Hospital Encompass Health has recently made a significant impact in the healthcare landscape by launching a new facility. The Encompass Health Rehabilitation Hospital of St. Petersburg is now officially open to patients, marking the company's 25th location in Florida. Quality Care for Patients This facility is aimed at improving...

Continue Reading